BioLife Plasma Services
The Research Strategy Development & Integration Lead serves as a senior strategic partner to drive Takeda Research's transformation priorities, including the flagship "Labs of Tomorrow" initiative. This role integrates scientific acumen with strategic capabilities to ensure coherent execution of AI, automation, and technology programs. The position requires evaluating technological possibilities and translating them into strategic options to deliver differentiated medicines efficiently.
Headquarters
Bannockburn, Illinois, United States
Company Size
5001-10000 employees
BioLife Plasma Services operates a network of plasma collection centers that collect donated human plasma used to manufacture life‑saving plasma‑derived therapies. The company focuses on donor safety and convenience, offering screening, regulated collection procedures, appointment scheduling, and compensation/rewards to encourage repeat donations. BioLife partners with biopharmaceutical manufacturers and maintains rigorous quality and regulatory standards to supply plasma for treatments such as immune deficiencies, bleeding disorders, and other therapeutic uses.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioLife Plasma Services.
Research Strategy Development & Integration Lead
Takeda Pharmaceutical Company Limited
Associate Director, Research Strategy Development
Takeda Pharmaceutical Company Limited
Executive Director, AIRx Program Lead
Takeda Pharmaceutical Company Limited
Senior Director, Research Scientific Liaison
Revolution Medicines
Senior / Research Scientist (In-vitro / Cellular Pharmacology - Peptides), London, Lausanne
Isomorphic Labs
AI Science Innovation Strategy Lead
AstraZeneca